Vitamin K-dependent coagulation cascade complexes (VKD complexes) (VKD complexes)

Vitamin K-dependent coagulation cascade complexes are essential multi-protein assemblies that regulate the formation of blood clots (StatPearls). These complexes include the extrinsic tenase, intrinsic tenase, and prothrombinase complexes, which consist of serine proteases (Factors II, VII, IX, and X) and their respective cofactors (NIH). The activity of these proteins depends on the post-translational gamma-carboxylation of glutamic acid residues, a process requiring Vitamin K as a cofactor (PubMed). This modification enables the proteins to bind calcium ions and associate with negatively charged phospholipid membranes on activated platelets (UniProt). Dysregulation of these complexes can lead to life-threatening conditions such as deep vein thrombosis, pulmonary embolism, or excessive bleeding. Consequently, these complexes are primary targets for anticoagulant therapies, including Vitamin K antagonists like warfarin and direct oral anticoagulants that specifically inhibit individual factors like Xa or thrombin. Monitoring these complexes is clinically vital, often achieved through tests like the International Normalized Ratio (INR) or Anti-Xa assays.

Other names

Vitamin K-dependent clotting factorsGla-domain containing proteinsProthrombinase complexTenase complexVitamin K-dependent proteins

Vitamin K antagonists inhibit the enzyme Vitamin K epoxide reductase (VKORC1), preventing the recycling of Vitamin K and thus the gamma-carboxylation of Factors II, VII, IX, and X (StatPearls). Direct oral anticoagulants (DOACs) act by binding directly to the active sites of specific factors, such as Factor Xa or Thrombin (Factor IIa), within their respective complexes to block their proteolytic activity (PubMed).